News

Jared Gollob, MD, chief medical officer at Kymera Therapeutics, reviews phase 1b data for KT-621, an oral STAT6 degrader being evaluated for atopic dermatitis.

Findings support ongoing pharmacovigilance monitoring of GLP-1 receptor agonists for hair loss, particularly as semaglutide and tirzepatide use continues to expand.

Amy Snow, MSPAS, PA-C's mobile nonprofit brings free acne treatment, education, and hope to underserved teens.

Christopher Bunick, MD, PhD, shares his insights on the FDA approval of bemotrizinol and what the ingredient's properties mean for sun protection and cosmetic elegance.

FDA clears lebrikizumab (EBGLYSS) every-8-week maintenance dosing for moderate to severe atopic dermatitis, reducing maintenance injections to as few as 6 per year.

This review of the latest dermatological studies includes insights on a mobile AI platform for skin disease prescreening, COVID-19 outcomes in PsO patients on biologics, i-PRF) and laser therapy for facial rejuvenation, and more.

Valerie Stern, DMSc, MPAS, PA-C, argues that dermatology conferences offer APPs something CME alone can't — a community that understands the specific professional pressures of the role.

Zoe Diana Draelos, MD, discusses how to clinically distinguish Malassezia folliculitis from acne vulgaris and when to consider antifungal therapy.

Meta-analysis finds azithromycin pulse therapy matches doxycycline for moderate to severe acne, with fewer GI adverse events and less photosensitivity.

Dual-layer microneedle patch delivers fast itch relief and sustained methotrexate-zinc therapy, improving psoriasis inflammation, immune balance, and infection protection in mice.

The FDA finalized the addition of bemotrizinol to the OTC sunscreen monograph, approving the broad-spectrum UV filter for use at concentrations up to 6% in adults and children 6 months or older.

The priority review pathway cuts the standard 300-day Canadian review timeline to approximately 180 days, reflecting Health Canada's assessment of serious unmet need in the EB population.

In clinical medicine and science, robust often fails because it lacks quantifiable meaning.

From case reports to conference presentations, Stern outlines a practical path APPs can follow to build a profile beyond their day-to-day clinical role.

AI analysis of 187,016 menopausal women links hair loss severity to thyroid disease, gut symptoms, scalp inflammation, and genetics, supporting broader diagnostic workups beyond hormones.

William Posten, MD, discusses outcomes, recurrence rates, and the importance of patient adherence in a combined surgical excision and radiation therapy protocol for keloids.

As Epiduo goes OTC, offering once-daily adapalene+BPO for mild to moderate acne, Heather Woolery-Lloyd, MD, FAAD, gives advice on irritation, purging, and simplifying routines.

The June issue of Dermatology Times highlights the latest advances in skin cancer, psoriasis, atopic dermatitis, hidradenitis suppurativa, and emerging dermatology technologies.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Translational Takeaways distills the most clinically relevant findings from emerging dermatology research into clear, practice-focused insights that inform real-world decision-making.

Can daily supplements "clear skin from within", or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Elizabeth Buzney, MD, provides an overview of the mechanism of action, administration protocol, and clinical safety profile of afamelanotide for erythropoietic protoporphyria.

Lakshi M. Aldredge, MSN, ANP-BC, DCNP, discusses late-breaking data preseneted at SDNP on novel immune-mediated therapies for atopic dermatitis, alopecia areata, and hidradenitis suppurativa.

Suneel Chilukuri, MD, explains why acne care requires a holistic approach that treats both visible lesions and the "mental scarring" that affects patient self-confidence.

Plant-based oat oil and aloe moisturizer outperforms metronidazole in a 12-week trial, reducing rosacea redness and lesions safely without irritation.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Learn why non-comedogenic moisturizers and hyaluronic acid support the skin barrier in acne patients, plus how patients can use benzoyl peroxide safely.

Deborah Sarnoff, MD, president of the Skin Cancer Foundation, discusses actinic keratosis detection, treatment, and clinician resources provided by the Skin Cancer Foundation.

As one of California's first derm PAs, Stern discusses the mentorship-driven private practice model that launched her career and its near-disappearance today.

Zoe Diana Draelos, MD, FAAD, discussed the clinical rationale for incorporating plant adaptogen-based skin care into rosacea management, including how an OTC serum performed alongside prescription therapies.